3型原发性高草酸尿症患者结石事件的特征分析
该研究回顾性分析罕见肾结石联盟原发性高草酸尿症注册登记中70例3型原发性高草酸尿症患者的临床与实验室数据,描述结石事件特征并分析其与尿液参数及肾功能的关系。结果显示65/70例(93%)发生肾结石,62/70例(89%)发生临床结石事件,随访10.7年期间终生结石事件率为0.19事件/年,326次临床结石事件中139次(42.6%)需手术干预;校正首次事件年龄后,较高的草酸钙过饱和度与终生结石事件率升高相关(IRR 1.23,95%CI 1.16-1.32,P<.001)。
要点
- 70例3型原发性高草酸尿症患者中65例(93%)发生肾结石,62例(89%)发生临床结石事件。
- 326次临床结石事件中139次(42.6%)需手术干预,随访10.7年期间终生结石事件率为0.19事件/年。
- 校正首次事件年龄后,较高的草酸钙过饱和度与终生结石事件率升高相关(IRR 1.23,95%CI 1.16-1.32,P<.001)。
核心结论
- 结石对3型原发性高草酸尿症患者构成终生负担,降低尿草酸钙过饱和度可能减少事件频率和手术干预。
研究设计与样本
- 回顾性分析罕见肾结石联盟原发性高草酸尿症注册登记中70例3型原发性高草酸尿症患者的临床与实验室数据。
主要发现
- 65/70例(93%)发生肾结石,49例有影像资料者首次影像中位结石数为4个(IQR 2-5),最大结石7 mm(IQR 4-10)。
- 62/70例(89%)发生临床结石事件,每例中位事件数3次(IQR 2-6,范围1-49),首次结石事件年龄为3岁(IQR 0.99-8.7)。
- 随访10.7年(IQR 4.2-26.3)期间终生结石事件率为0.19事件/年(IQR 0.12-0.38)。
- 326次临床结石事件中139次(42.6%)需手术干预,多数患者高结石事件率持续至第六个十年。
- 55枚结石分析中纯草酸钙占69%,草酸钙与磷酸钙混合占22%;校正首次事件年龄后,较高草酸钙过饱和度与终生结石事件率升高相关(IRR 1.23,95%CI 1.16-1.32,P<.001)。
关键数值与推荐
- 结石成分分析:纯草酸钙69%,草酸钙与磷酸钙混合22%(共分析55枚结石)。
- 较高草酸钙过饱和度与终生结石事件率升高相关(IRR 1.23,95%CI 1.16-1.32,P<.001),校正首次事件年龄。
临床怎么用
- 原文结论认为降低尿草酸钙过饱和度可能减少事件频率和手术干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hallmarks of primary hyperoxaluria type 3 are nephrolithiasis and hyperoxaluria. However, little is known about factors influencing stone formation in this disease. We characterized stone events and examined associations with urine parameters and kidney function in a primary hyperoxaluria type 3 population. MATERIALS AND METHODS: We retrospectively analyzed clinical, and laboratory data of 70 primary hyperoxaluria type 3 patients enrolled in the Rare Kidney Stone Consortium Primary Hyperoxaluria Registry. RESULTS: Kidney stones occurred in 65/70 primary hyperoxaluria type 3 patients (93%). Among the 49 patients with imaging available, the median (IQR) number of stones was 4 (2, 5), with largest stone 7 mm (4, 10) at first imaging. Clinical stone events occurred in 62/70 (89%) with median number of events per patient 3 (2, 6; range 1-49). Age at first stone event was 3 years (0.99, 8.7). Lifetime stone event rate was 0.19 events/year (0.12, 0.38) during follow-up of 10.7 (4.2, 26.3) years. Among 326 total clinical stone events, 139 (42.6%) required surgical intervention. High stone event rates persisted for most patients through the sixth decade of life. Analysis was available for 55 stones: pure calcium oxalate accounted for 69%, with mixed calcium oxalate and phosphate in 22%. Higher calcium oxalate supersaturation was associated with increased lifetime stone event rate after adjusting for age at first event (IRR [95%CI] 1.23 [1.16, 1.32]; P < .001). By the fourth decade, estimated glomerular filtration rate was lower in primary hyperoxaluria type 3 patients than the general population. CONCLUSIONS: Stones impose a lifelong burden on primary hyperoxaluria type 3 patients. Reducing urinary calcium oxalate supersaturation may reduce event frequency and surgical intervention.
引用
- Arnous MG, Vaughan L, Mehta RA, et al. Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria. J Urol. 2023. PMID: 36888927. doi:10.1097/JU.0000000000003400
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。